hrp0097rfc3.4 | Fat, metabolism and obesity 1 | ESPE2023

Effect of maternal diet and breastfeeding on growth and distribution of adiposity from birth up to 12 months: data from the European LIFE-MILCH project

Righi Beatrice , Alberghi Francesca , Fontana Marta , Pelosi Annalisa , Davolio Emanuela , Rotteglia Cecilia , Catellani Cecilia , Sartori Chiara , Shulhai Anna-Mariia , Buia Veronica , Maria Papini Anna , Fanos Vassilios , Palanza Paola , E Street Maria

The ongoing European LIFE-MILCH project(www.lifemilch.eu), focuses on detecting Endocrine Disrupting Chemicals in mothers, in breast and formula milk and in urine of mothers and infants up to 12 months of age studying relationships with neurodevelopment, growth, distribution of adiposity, pubertal stages to establish a risk assessment model to prepare safety guidelines. In this study we have evaluated the effects of maternal diet during and after pregnancy, and of duration of ...

hrp0097p1-371 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023

Effect of maternal diet on pubertal stages and ano-genital distance from birth up to 12 months: data from the European LIFE-MILCH project

Alberghi Francesca , Fontana Marta , Righi Beatrice , Shulhai Anna-Mariia , Davolio Emanuela , Rotteglia Cecilia , Pelosi Annalisa , Catellani Cecilia , Sartori Chiara , Buia Veronica , Maria Papini Anna , Fanos Vassilios , Palanza Paola , E. Street Maria

The ongoing European LIFE-MILCH project (www.lifemilch.eu), focuses on detecting Endocrine Disrupting Chemicals in mothers, in breast and formula milk and in urine of mothers and infants up to 12 months of age studying relationships with neurodevelopment, growth, distribution of adiposity, pubertal stages, and ano-genital distance (AGD) to establish a risk assessment model to prepare safety guidelines. In this study we evaluated the effects of maternal diet during and after pr...

hrp0082p3-d1-906 | Pituitary | ESPE2014

Pituitary Dysfunctiona with Associated Lesions in the Hypothalamo-Pituitary Region: Histiocytosis or Dysgerminoma?

Vlachopapadopoulou Elpis , Papadakis Vassilios , Nomikos Panagiotis , Michalacos Stefanos , Polychronopoulou Sophia

Background: Patients who present with clinical and laboratory findings of pituitary dysfunction and whose MRI findings reveal increased pituitary size or thickening of pituitary stalk, pose a diagnostic challenge. The differential diagnosis mainly includes dysgerminoma, histiocytosis, and hypophysitis. A non-invasive approach is often non-diagnostic.Objective and hypotheses: To present two patients with similar clinical picture and positive MRI findings,...

hrp0092p1-432 | Thyroid (2) | ESPE2019

Levothyroxine Effect on Thyroid Volume in Children with Autoimmune Hashimoto Thyroiditis (AHT) Presenting Subclinical (SH) or Overt (Oh) Hypothyroidism

Leka-Emiri Sofia , Petrou Vassilios , Evangelopoulou Cathrine , Vakaki Marina , Fotinou Aspasia , Vlachopapadopoulou Elpis , Michalacos Stefanos

Objectives: Assess thyroid volume in relation to TSH and FT4 at diagnosis of AHT and 2.9 years of follow up in children with SH or OH.Methods: wo hundred one children (155 girls) with AHT were divided according to TSH and FT4 levels [SH-FT4 >1.0 ng/dl: Group 1: TSH: 5-7.5 mU/l, Group 2: TSH: >7.5 mU/l, OH: Group 3: TSH>7.5 mU/l and FT4 ≤1.0ng/dl]. Mean L-T4 dose is reported in µg/Kg/day. Thyroid...

hrp0089p3-p259 | Growth & Syndromes P3 | ESPE2018

17p13.1 Microduplication Syndrome in a Child with Familial Short Stature and GH Deficiency: A Short Case Report

Leka-Emiri Sofia , Petrou Vassilios , Manolakos Emmanouil , Fotinou Aspasia , Thomaidis Loretta , Vlachopapadopoulou Elpis , Michalacos Stefanos

Background: To date, six cases of 17p13.1 microduplications have been described in the literature. Intellectual disability is the core feature, together with minor facial dysmorphisms and obesity later in life, but a characteristic phenotype for 17p13.1 microduplication has not been delineated.Objective and hypothesis: We describe a young patient with a 422 Kb microduplication maternally inherited in 17p13.1, affected by mild intellectual disability and ...

hrp0089p3-p391 | Thyroid P3 | ESPE2018

Levothyroxine Treatment of Subclinical (SH) and Overt (OH) Hypothyroidism in Children with Autoimmune Hashimoto Thyroiditis (AHT): A Retrospective Study in Regard with TSH and Free T4 (FT4) at Diagnosis

Leka-EmirI Sofia , Petrou Vassilios , Evangelopoulou Cathrine , Kafetzi Maria , Fotinou Aspasia , Vlachopapadopoulou Elpis , Michalacos Stefanos

Objectives: Assess the dose of levothyroxine in relation to TSH and FT4 levels at diagnosis of AHT in children with SH and OH.Methods: Eighty eight children (69 girls) with AHT were devised in regard with TSH and FT4 at diagnosis [SH-FT4 >0.9 ng/dl: Group 1: TSH: 4.5-7 mU/l, Group 2: TSH: 7-10 mU/l, Group 3: TSH: >10 mU/l and OH: Group 4: TSH>10 mU/l and FT4 ≤0.9 ng/dl]. Mean L-T4 dose was reported in μgr/Kg per day at diagnosis an...

hrp0084p3-878 | Fat | ESPE2015

Obese Children and Adolescents: Reasons for Non-compliance with Follow-up Scheduling

Drosatou Chrysoula , Vlachopapadopoulou Elpis-Athina , Karachaliou Feneli , Dikaiakou Eirini , Anagnostou Elli , Patinioti Ioanna , Petrou Vassilios , Michalakos Stefanos

Background: Non-compliance is a major issue for treatment failure in childhood obesity.Objective and hypotheses: To identify the barriers of adherence to weight management programs, of obese children and adolescents.Method: A descriptive, ongoing study based on phone recorded questionnaires with the use of information from the medical records. The study group consisted of 85 overweight and obese children and adolescents (M/F=46/39)...

hrp0082p2-d2-422 | Growth Hormone (1) | ESPE2014

Perceptions and Expectations of Patients and their Families for the Effects of GH Treatment

Drosatou Chrysoula , Vlachopapadopoulou Elpis-Athina , Karachaliou Feneli , Petrou Vassileios , Kaloumenou Eirini , Michalakos Stefanos

Background: Children’s and parents’ expectations regarding GH therapy results have been previously assessed. However, there are limited data on children’s and adolescents perceptions of their own body size as compared with that of their age-related peers, as well as their expectations of their final stature.Objective and hypotheses: To evaluate the perceptions of GH treated children and their families for the child’s stature and to as...

hrp0082p3-d1-818 | Growth | ESPE2014

Assessment of Compliance with GH Therapy

Drosatou Chrysoula , Karachaliou Feneli , Vlachopapadopoulou Elpis-Ahina , Petrou Vassileios , Kaloumenou Eirini , Michalakos Stefanos

Background: Treatment compliance is one of the most important practical aspects in long-term treatments such as GH therapy.Objective and hypotheses: To evaluate the level of compliance and its association with duration of treatment and other demographic factors.Method: A prospective study with the use of validated questionnaires was conducted in the Endocrinology Department of one of the two main Pediatric Hospitals in Athens. The ...

hrp0086p2-p76 | Adrenal P2 | ESPE2016

High Sensitivity C-Reactive Protein (hsCRP) Levels as Predictor of Salivary Cortisol Acute Response to Mental Stress and/or Mobile Phone Call in Healthy Adolescents

Geronikolou Styliani , Vasdekis Vassilis , Cokkinos Dennis , Chrousos George , Kanaka-Gantenbein Christina

Background: The hypothalamic–pituitary–adrenal (HPA) axis responds to several acute or chronic environmental stessors, including those of social stress.Objective and hypotheses: To assess the HPA axis acute response during mental stress and mobile phone call exposure in healthy adolescents through salivary cortisol measurements and to investigate the modulatory effect of baseline biochemical or low-inflammation markers during this response....